Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BLNDNYSE:PSNNASDAQ:TEM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLNDBlend Labs$3.23-8.1%$3.40$2.08▼$5.53$837.41M1.33.01 million shs1.92 million shsPSNParsons$69.74-0.9%$65.98$54.56▼$114.68$7.45B0.531.19 million shs1.09 million shsTEMTempus AI$71.220.0%$55.90$22.89▼$91.45$12.33BN/A6.98 million shs12.80 million shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLNDBlend Labs0.00%-14.00%-12.01%-9.79%+31.63%PSNParsons0.00%+1.04%+1.03%+17.92%-8.61%TEMTempus AI0.00%+14.74%+8.75%+42.82%+7,122,199,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLNDBlend Labs3.7524 of 5 stars4.43.00.00.02.53.30.6PSNParsons3.3324 of 5 stars3.33.00.00.01.91.72.5TEMTempus AI1.6516 of 5 stars2.32.00.00.02.92.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLNDBlend Labs 2.89Moderate Buy$4.9051.94% UpsidePSNParsons 2.58Moderate Buy$86.9024.61% UpsideTEMTempus AI 2.54Moderate Buy$63.42-10.96% DownsideCurrent Analyst Ratings BreakdownLatest TEM, PSN, VTY, and BLND Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/4/2025PSNParsonsThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$90.00 ➝ $80.006/3/2025PSNParsonsBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$100.00 ➝ $95.005/28/2025BLNDBlend LabsJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$7.005/20/2025TEMTempus AIBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$48.00 ➝ $68.005/19/2025BLNDBlend LabsKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetMarket Perform ➝ Market Perform$3.50 ➝ $4.005/15/2025TEMTempus AIPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$55.00 ➝ $70.005/12/2025BLNDBlend LabsThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$5.60 ➝ $4.805/12/2025BLNDBlend LabsCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$5.25 ➝ $5.255/9/2025TEMTempus AIMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$60.00 ➝ $65.005/7/2025TEMTempus AINeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$70.00 ➝ $70.005/5/2025PSNParsonsJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold$75.00 ➝ $65.00(Data available from 6/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLNDBlend Labs$164.95M5.08N/AN/A($0.08) per share-40.31PSNParsons$6.77B1.10$4.36 per share16.00$23.74 per share2.94TEMTempus AI$803.32M15.35N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLNDBlend Labs-$178.69M-$0.20N/AN/AN/A-49.34%N/A-34.07%8/14/2025 (Estimated)PSNParsons$161.15M$2.3791.7617.010.931.30%12.82%5.73%7/30/2025 (Estimated)TEMTempus AI-$289.81M-$7.80N/AN/AN/AN/AN/A-111.38%8/5/2025 (Estimated)Latest TEM, PSN, VTY, and BLND EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2025Q1 2025TEMTempus AI-$0.27-$0.24+$0.03-$0.40$248.13 million$255.74 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLNDBlend LabsN/AN/AN/AN/AN/APSNParsonsN/AN/AN/AN/AN/ATEMTempus AIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLNDBlend LabsN/A3.243.24PSNParsons0.311.291.55TEMTempus AI8.172.692.55Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLNDBlend Labs52.56%PSNParsons98.02%TEMTempus AI24.22%Insider OwnershipCompanyInsider OwnershipBLNDBlend Labs35.52%PSNParsons1.14%TEMTempus AI27.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLNDBlend Labs1,690259.66 million222.12 millionNot OptionablePSNParsons6,180106.88 million46.72 millionNot OptionableTEMTempus AI2,300173.12 millionN/AN/ATEM, AVST, PSN, and BLND HeadlinesRecent News About These CompaniesTEM Investor Notice: Robbins LLP Reminds Shareholders of the Class Action Lawsuit Against ...June 15 at 4:57 PM | bakersfield.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tempus AI, Inc. ...June 15 at 10:30 AM | gurufocus.comTempus AI (NasdaqGS:TEM) Soars 51% In Last QuarterJune 14 at 2:50 PM | finance.yahoo.comTempus AI, Inc. (NASDAQ:TEM) Director Theodore Leonsis Sells 205,847 SharesJune 14 at 7:20 AM | insidertrades.comTEMPUS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Tempus AI, Inc. and Encourages Investors to Contact the FirmJune 13 at 9:00 PM | globenewswire.comTEM Investor Notice: Robbins LLP Reminds Shareholders of the Class Action Lawsuit Against Tempus AI, Inc. Class ActionJune 13 at 8:31 PM | globenewswire.comTempus Investor Sues Over Short Seller’s AI, CEO AccusationsJune 13 at 7:03 PM | news.bloomberglaw.comTempus AI, Inc. (NASDAQ:TEM) Director Sells $13,927,608.02 in StockJune 13 at 6:11 PM | marketbeat.comTEM Investor News: If You Have Suffered Losses in Tempus AI, Inc. (NASDAQ: TEM), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJune 13 at 4:39 PM | globenewswire.comShamis & Gentile, P.A. Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Tempus AI, Inc. and Sets a Lead Plaintiff Deadline of August 12, 2025June 13 at 3:00 PM | globenewswire.comTempus AI's Expanding Ties Boost Novel R&D Efforts and Market ReachJune 13 at 1:11 PM | zacks.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tempus AI, Inc. - TEMJune 13 at 10:00 AM | accessnewswire.comShareholder Alert: Robbins LLP Informs Investors of the Tempus AI, Inc. Class ActionJune 13 at 6:01 AM | prnewswire.comTempus, Northwestern partner to focus AI on Alzheimer's researchJune 13 at 12:46 AM | chicagobusiness.comVeteran analyst unveils bold price target for Tempus AI stockJune 13 at 12:46 AM | msn.comThese 24 Stocks Are Ripe for a Short SqueezeJune 12, 2025 | schaeffersresearch.comBronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Tempus AI, Inc. (TEM) and Encourages Shareholders to Learn More About the InvestigationJune 12, 2025 | accessnewswire.comTempus Announces Collaboration with Northwestern University's Abrams Research Center on Neurogenomics to Leverage AI for Alzheimer's Disease ResearchJune 12, 2025 | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tempus AI, Inc. - TEMJune 12, 2025 | prnewswire.comTempus AI, Inc. (NASDAQ:TEM) Shares Acquired by Avanza Fonder ABJune 12, 2025 | marketbeat.comTempus AI (TEM) and Its Peers Head-To-Head AnalysisJune 12, 2025 | americanbankingnews.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeQuantum Stocks Skyrocket, Led by IonQ's NVIDIA DeclarationBy Leo Miller | May 27, 2025View Quantum Stocks Skyrocket, Led by IonQ's NVIDIA DeclarationAfter Earnings Beats, These 3 Stocks Are on Analysts’ RadarsBy Leo Miller | May 20, 2025View After Earnings Beats, These 3 Stocks Are on Analysts’ RadarsNVIDIA’s NVLink Fusion Ups the Ante for AI InfrastructureBy Thomas Hughes | May 19, 2025View NVIDIA’s NVLink Fusion Ups the Ante for AI InfrastructureD-Wave Quantum Stock: Are Advantage2 Gains Here to Stay?By Nathan Reiff | May 28, 2025View D-Wave Quantum Stock: Are Advantage2 Gains Here to Stay?TEM, AVST, PSN, and BLND Company DescriptionsBlend Labs NYSE:BLND$3.22 -0.29 (-8.12%) Closing price 06/13/2025 03:59 PM EasternExtended Trading$3.28 +0.05 (+1.71%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Blend Labs, Inc. engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty. It also offers verification components to automate confirmation tasks that are needed to underwrite a loan or approve the opening of a new deposit account; decisioning components to reduce the need for human intervention by automatically applying business rules throughout an application workflow configured by a financial services firm; workflow intelligence components to manage data collection and automate tasks throughout the loan origination process; and marketplace components to enable consumers to shop for products and services presented at the precise moment of need during an application for a loan. In addition, the company, through its subsidiary, offers title search procedures for title insurance policies, escrow, and other closing and settlement services, as well as other trustee services; and provides professional and consulting services. It serves banks, credit unions, fintechs, and non-bank mortgage lenders. The company was incorporated in 2012 and is headquartered in San Francisco, California.Parsons NYSE:PSN$69.74 -0.64 (-0.91%) Closing price 06/13/2025 03:59 PM EasternExtended Trading$69.64 -0.10 (-0.14%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Parsons Corporation provides integrated solutions and services in the defense, intelligence, and critical infrastructure markets in North America, the Middle East, and internationally. The company operates through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment provides critical technologies, such as cybersecurity; missile defense; intelligence; space launch and ground systems; space and weapon system resiliency; geospatial intelligence; signals intelligence; environmental remediation; border security, critical infrastructure protection; counter unmanned air systems; biometrics and bio surveillance solutions to U.S. Department of Defense, including military services; Missile Defense Agency, the Department of Energy; the Department of State; the Department of Homeland Security, and the Federal Aviation Administration. The Critical Infrastructure segment provides management, design, and engineering services, as well as offers leveraging sensor solutions. This segment develops digital solutions for next generation aviation, rail and transit, bridges, roads, and highways; and provides water and wastewater treatment systems; AI/ML, and digital twin and cyber systems integration services; planning, engineering, and management services for infrastructure, including bridges and tunnels, roads and highways, water and wastewater, and dams and reservoirs. Parsons Corporation was founded in 1944 and is headquartered in Chantilly, Virginia.Tempus AI NASDAQ:TEM$71.22 -0.01 (-0.01%) Closing price 06/13/2025 03:59 PM EasternExtended Trading$72.47 +1.25 (+1.76%) As of 06:41 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/09 - 06/13 Alphabet Enters a Bull Market: Is It Time to Buy? Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones RH Stock Rockets on Surprise Profit and Tariff Shift Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
